StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
120
This month
3
This year
13
Publishing Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 10 - 20
2
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 02 - 24
1
2021 - 02 - 17
1
2021 - 02 - 09
1
2021 - 02 - 03
1
2021 - 01 - 05
1
2021 - 01 - 04
1
2020 - 12 - 22
1
2020 - 12 - 11
1
2020 - 12 - 03
2
2020 - 12 - 02
1
Sector
Finance
6
Finance and insurance
4
Health technology
120
Manufacturing
1
Tags
Aml
1
Antibody
2
Asco
1
Biotech
1
Blood
1
Business
8
Cancer
6
Candidate
2
Cell
3
Change
1
Clearance
1
Clinical-trials-phase-ii
5
Clinical-trials-phase-iii
3
Collaboration
2
Commercialization
1
Company announcement
1
Conference
28
Covid
1
Covid-19
1
Designation
1
Disease
1
Drug
4
Earnings
10
Europe
13
Events
24
Expansion
3
Fast track designation
1
Fda
2
Financial
11
Financial results
4
First
1
Growth
1
Iph45
2
Iph5201
2
Iph6101
4
Iph6401
1
Iph6501
1
Money
2
N/a
35
Natural
2
Ongoing
2
Pharma
103
Pharmaceutical
15
Phase 2
5
Phase 3
2
Platform
2
Preclinical
2
Presentation
3
Program
4
Regulatory
5
Report
5
Research
3
Results
18
Sanofi
6
Study
3
Therapeutics
2
Trial
11
Universal
2
Update
15
Year
4
Entities
Abbvie inc.
1
Amgen inc.
1
Argenx se
1
Astellas pharma inc
1
Astrazeneca plc
4
Biogen inc.
1
Bnp paribas
4
Bristol-myers squibb company
2
Denali therapeutics inc.
1
Eli lilly and company
1
Glaxosmithkline plc
1
Incyte corporation
1
Innate pharma s.a.
120
Innate pharma sa
80
Johnson & johnson
1
Morgan stanley
1
Novartis ag
1
Novo nordisk a/s
71
Sanofi
109
Svb financial group
1
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
1
Vertex pharmaceuticals incorporated
1
Zai lab limited
1
Symbols
A
429
ABBV
1029
ABT
1796
ALPMF
333
ALPMY
333
AMGN
744
AZN
667
AZNCF
450
BAX
484
BDX
796
BGNE
324
BHC
389
BIIB
381
BIO
449
BMY
662
BNTX
367
BSX
576
BWAY
330
DHR
786
FNCTF
490
GILD
500
GLAXF
661
GMAB
298
GOOG
306
GOOGL
307
GSK
887
HEPA
404
HOLX
328
ILMN
451
INCY
445
JNJ
4594
LLY
1710
MDT
1285
MOR
318
MPSYF
274
MRK
337
MRNA
350
MS
621
NKTR
369
NVO
634
NVS
1243
NVSEF
1033
OCX
485
PFE
693
PHG
963
PKI
274
PRVB
348
QGEN
369
REGN
421
RYLPF
440
SNY
4550
SNYNF
3608
STRO
270
SYK
536
TAK
423
TEVJF
632
TMO
1626
TXMD
281
VTRS
365
VXRT
317
Exchanges
Nasdaq
120
Nyse
74
Crawled Date
2024 - 03 - 06
2
2024 - 01 - 04
2
2023 - 05 - 03
2
2022 - 10 - 20
2
2022 - 06 - 23
1
2022 - 06 - 03
1
2022 - 05 - 11
1
2022 - 05 - 10
1
2022 - 05 - 03
1
2022 - 04 - 29
1
2022 - 04 - 08
1
2022 - 04 - 05
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 04
1
2022 - 01 - 24
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 16
1
2021 - 12 - 09
1
2021 - 12 - 02
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 09
1
2021 - 10 - 26
1
2021 - 10 - 15
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 15
1
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 30
2
2021 - 08 - 11
1
2021 - 07 - 12
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 06 - 16
1
2021 - 06 - 14
1
2021 - 06 - 10
1
2021 - 06 - 09
2
2021 - 05 - 28
1
2021 - 05 - 25
1
2021 - 05 - 12
1
2021 - 05 - 11
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 21
1
2021 - 04 - 19
1
2021 - 03 - 18
2
2021 - 03 - 16
1
2021 - 02 - 24
1
2021 - 02 - 17
1
2021 - 02 - 09
1
2021 - 02 - 03
1
2021 - 01 - 05
1
2021 - 01 - 04
1
2020 - 12 - 22
1
2020 - 12 - 11
1
2020 - 12 - 03
2
2020 - 12 - 02
1
Crawled Time
02:08
1
05:00
2
06:00
27
06:01
2
07:00
22
08:00
19
09:00
18
10:00
8
11:00
10
12:00
5
12:30
1
14:02
1
15:00
1
20:00
1
22:00
1
23:00
1
Source
www.biospace.com
83
www.globenewswire.com
34
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
IPHA
save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published:
2024-04-10
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-6.92%
|
O:
-3.85%
H:
1.2%
C:
0.8%
iph45
pharma
drug
candidate
antibody
preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published:
2024-04-09
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.38%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.21%
|
O:
-0.38%
H:
0.95%
C:
0.83%
IPHA
|
$2.425
530
|
Health Technology
|
-2.81%
|
O:
2.57%
H:
1.81%
C:
1.81%
pharma
conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published:
2024-04-05
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-4.77%
|
O:
-3.44%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-3.2%
|
O:
-0.4%
H:
0.0%
C:
-5.22%
pharma
report
universal
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published:
2024-03-21
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.21%
|
O:
0.3%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-3.2%
|
O:
-4.51%
H:
4.25%
C:
0.96%
pharma
business
year
update
financial
results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published:
2024-03-19
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.31%
|
O:
-0.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-3.65%
|
O:
-1.51%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
1.26%
|
O:
0.84%
H:
4.56%
C:
0.83%
pharma
conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published:
2024-03-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-4.23%
|
O:
0.23%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-3.2%
|
O:
-2.4%
H:
3.69%
C:
3.28%
pharma
conference
year
financial
results
Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma
Published:
2024-03-06
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.68%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-5.84%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph6501
first
study
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published:
2024-03-06
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.68%
|
O:
-0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-5.84%
|
O:
0.78%
H:
1.93%
C:
0.97%
iph45
pharma
drug
antibody
preclinical
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published:
2024-02-21
(Crawled : 07:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-1.49%
|
O:
1.7%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-2.37%
|
O:
-0.57%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-6.56%
|
O:
-2.32%
H:
0.0%
C:
0.0%
pharma
conference
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
-1.11%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.73
3.7K
|
Health Technology
|
14.97%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
News
|
$9.53
690K
|
Manufacturing
|
-11.92%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.35
-0.08%
230K
|
Health Technology
|
-6.64%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
News
|
$98.12
3.15%
1.1M
|
Health Technology
|
-5.73%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$148.24
-0.59%
1.6M
|
Health Technology
|
-4.78%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.865
0.68%
320K
|
Health Technology
|
-1.17%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$739.11
1.06%
320K
|
Health Technology
|
-0.8%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$49.28
0.29%
800K
|
Health Technology
|
-1.23%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.22
0.79%
370K
|
Health Technology
|
-2.99%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$15.325
2.24%
87K
|
Health Technology
|
-17.68%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
$406.755
1.71%
180K
|
Health Technology
|
-5.01%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
0.16%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-6.2%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$51.475
-0.86%
230K
|
Health Technology
|
-10.24%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.76
0.34%
110K
|
Health Technology
|
-20.69%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$70.47
0.49%
990K
|
Health Technology
|
14.2%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$371.055
0.63%
58K
|
Health Technology
|
-6.1%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
News
|
$272.245
0.12%
220K
|
Health Technology
|
-7.65%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published:
2024-01-12
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-11.92%
|
O:
0.71%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-11.59%
|
O:
0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-13.26%
|
O:
0.0%
H:
0.36%
C:
0.36%
pharma
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published:
2024-01-04
(Crawled : 09:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-7.56%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.425
530
|
Health Technology
|
-12.95%
|
O:
6.47%
H:
3.65%
C:
-2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published:
2024-01-04
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-7.51%
|
O:
1.62%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-7.56%
|
O:
1.12%
H:
0.93%
C:
0.77%
IPHA
|
$2.425
530
|
Health Technology
|
-12.95%
|
O:
6.47%
H:
3.65%
C:
-2.36%
fda
pharma
program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published:
2023-12-19
(Crawled : 08:00)
- biospace.com/
NVO
|
News
|
$127.41
1.72%
750K
|
Health Technology
|
26.55%
|
O:
0.91%
H:
0.72%
C:
0.11%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-4.49%
|
O:
0.45%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-1.22%
|
O:
13.88%
H:
0.0%
C:
-3.58%
pharma
natural
cell
sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published:
2023-12-18
(Crawled : 10:00)
- biospace.com/
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-3.29%
|
O:
1.25%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
0.41%
|
O:
2.9%
H:
2.02%
C:
-1.21%
pharma
change
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published:
2023-12-11
(Crawled : 08:00)
- biospace.com/
IPHYF
|
$2.65
104.6%
300
|
Health Technology
|
11.81%
|
O:
9.45%
H:
0.0%
C:
-1.7%
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-0.54%
|
O:
0.5%
H:
1.67%
C:
0.1%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
0.14%
|
O:
2.15%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-6.2%
|
O:
-1.16%
H:
0.39%
C:
-4.31%
sar4435
pharma
iph6101
cell
results
sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published:
2023-11-27
(Crawled : 11:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-2.62%
|
O:
-0.36%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-1.77%
|
O:
1.04%
H:
0.17%
C:
0.11%
IPHA
|
$2.425
530
|
Health Technology
|
0.0%
|
O:
2.07%
H:
1.21%
C:
1.21%
pharma
Innate Pharma Reports Third Quarter 2023 Financial Results and Business Update
Published:
2023-11-14
(Crawled : 09:00)
- biospace.com/
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
1.97%
|
O:
0.68%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
6.61%
|
O:
6.61%
H:
9.39%
C:
6.61%
pharma
business
update
financial
results
Innate Pharma Announces Conference Call for Third Quarter 2023 Business Update
Published:
2023-11-07
(Crawled : 08:00)
- biospace.com/
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
1.31%
|
O:
-1.32%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-6.92%
|
O:
-2.31%
H:
2.76%
C:
1.18%
pharma
conference
business
update
Innate Pharma Announces Its Participation to Upcoming November 2023 Investor Conferences
Published:
2023-10-27
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$92.7
600K
|
Health Technology
|
-11.93%
|
O:
-18.18%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.375
0.48%
300K
|
Health Technology
|
-12.92%
|
O:
-15.73%
H:
0.0%
C:
0.0%
IPHA
|
$2.425
530
|
Health Technology
|
-1.63%
|
O:
-2.85%
H:
12.13%
C:
3.77%
pharma
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
89%
11%
Top 10 Gainers
MTTR
|
News
M
|
$4.65
167.24%
9.8M
|
AGBA
|
$2.46
96.8%
28M
|
Finance
EDBL
|
News
|
$6.94
84.57%
1.4M
|
CZOO
|
$7.74
55.11%
2.7M
|
VNRX
|
$0.84
40.0%
2.6M
|
Health Technology
ZAPP
|
$6.02
35.59%
95K
|
n/a
OPRT
|
News
|
$3.01
33.78%
6.8M
|
Finance
MLEC
|
$1.81
29.29%
2M
|
n/a
MTC
|
$2.0
28.21%
1.7M
|
Technology Services
PEGY
|
$0.0586
27.95%
130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.